3D neuroblastoma in vitro models using engineered cell-derived matrices

last updated: 2020-08-31
Project2MATCH :: publications list
Title3D neuroblastoma in vitro models using engineered cell-derived matrices
Publication TypeBook Chapter
Year of Publication2020
AuthorsAlmici E., Caballero D., Montero J., and Samitier J.
EditorsKundu S. C., and Reis R. L.
Abstract Text

Neuroblastoma (NB) is a malignant tumor that affects the peripheral nervous system and represents one of the most frequent cancers in infants. Its prognosis is poor in older patients and the presence of genetic abnormalities. Metastasis is often present at the time of diagnosis, making treatment more intensive and unsuccessful. Poor prognosis and variable treatment efficacy require a better understanding of the underlying biology. Evidence has shown that the tumor microenvironment is characteristic of tumor malignancy and progression. A more highly differentiated tissue phenotype represents a positive prognostic marker, while the tumoral tissue is characterized by a distinct composition and morphology of the extracellular matrix. In this chapter, we discuss the application of decellularized cell-derived matrices (CDM) to model in vitro the morphology of the extracellular matrix encountered in histological hallmarks of NB patients. This technique allows for the in vitro reproduction of the fine structure and composition of native microenvironments. Because of recent advances in culture systems and decellularization techniques, it is possible to engineer CDM composition and microarchitecture to produce differentiated models of tissue niches. The final goal is to repopulate the “scaffold” with malignant NB cells for drug screening and target discovery applications, studying the impact of patient-inspired tissues on signaling, migration, and tissue remodeling.

Book TitleBiomaterials for 3D tumor modeling
ISBN 9780128181287
Keywordsbioengineering, Cell-derived matrices, neuroblastoma model
Peer reviewedno

Back to top